A clinical study of NM441

NM441, a new quinolone antibiotic, was administered to 3 patients with respiratory tract infections (2 with chronic bronchitis and 1 with pulmonary emphysema + infection), and the clinical efficacy and safety of this drug were investigated. NM441 was administered at a dose of 100mg twice a day for 1...

Full description

Saved in:
Bibliographic Details
Published inJapanese Journal of Chemotherapy Vol. 44; no. Supplement1; pp. 635 - 636
Main Authors Tsubura, Eiro, Masuno, Tomiya
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1996
公益社団法人 日本化学療法学会
Subjects
NM394
NM441
ニューキノロン系合成抗菌剤
呼吸器感染症
Online AccessGet full text
ISSN1340-7007
1884-5886
DOI10.11250/chemotherapy1995.44.Supplement1_635

Cover

More Information
Summary:NM441, a new quinolone antibiotic, was administered to 3 patients with respiratory tract infections (2 with chronic bronchitis and 1 with pulmonary emphysema + infection), and the clinical efficacy and safety of this drug were investigated. NM441 was administered at a dose of 100mg twice a day for 13-14days. The clinical response was good in 1 and poor in 2 of 3 cases. No side effects were observed, but mild elevation of S-GOT and S-GPT was observed in 1 patient.
ISSN:1340-7007
1884-5886
DOI:10.11250/chemotherapy1995.44.Supplement1_635